Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep886 | Late Breaking | ECE2021

Hematological changes before and after radioactive iodine therapy

leyla akdoğan , Burcak Polat Sefika , Fatma Neslihan Cuhaci Seyrek , Ali Tam Abbas , Ozdemir Elif , Aydin Cevdet , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

ObjectiveRadioactive iodine (RAI) therapy is widely used in both diagnosis and treatment of benign and malignant thyroid diseases. It is generally a well tolerated therapy. Bone marrow suppression is often a temporary side effect with a decrease in white blood cells and platelets up to 6–10 weeks. In this study, we aimed to examine hematological changes in patients who received RAI treatment for benign or malignant diseases of the thyroid.<p cla...

ea0070aep209 | Bone and Calcium | ECE2020

Can serum calcium, phosphorus and parathyroid hormone levels predict histopathological diagnosis in patients with primary hyperparathyroidism?

Dirikoc Ahmet , Baser Husniye , Neslihan Cuhaci Seyrek Fatma , Polat Burcak , Ögmen Berna , Ali Tam Abbas , Aydın Cevdet , Kilic Yazgan Aylin , Kilic Mehmet , Ozdemir Didem , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

Aim: While the histopathological diagnosis is parathyroid adenoma in majority of patients with primary hyperparathyroidism (PHPT),parathyroid hyperplasia, atypical parathyroid adenoma or parathyroid carcinoma can be seen in others. Although it is known that serum calcium (Ca) and parathyroid hormone (PTH) levels are higher in patients with parathyroid carcinoma, there are not any cut-off value for serum Ca, phosphorus (P) and PTH levels defined for different histopathological ...